Outcome of bilateral adrenalectomy in congenital adrenal hyperplasia: one unit's experience

Cara Megan Ogilvie1, Gill Rumsby, Tom Kurzawinski

  • 1Department of Endocrinology, University College London Hospitals, UK.

Insights

Bilateral adrenalectomy may benefit selected women with congenital adrenal hyperplasia (CAH) seeking fertility, but carries risks for those managing hyperandrogenism. Further data is needed for broader recommendations.

Area of Science:

  • Endocrinology
  • Surgical Management
  • Reproductive Health

Background:

  • Congenital adrenal hyperplasia (CAH) management is complex, with bilateral adrenalectomy being a controversial therapeutic option.
  • This study reviews outcomes in five adult CAH patients who underwent adrenalectomy at a tertiary clinic.

Observation:

  • Two patients underwent adrenalectomy for fertility, achieving successful outcomes without adrenal crises.
  • Three patients had adrenalectomy for unsuppressible hyperandrogenism and obesity, experiencing improved appearance but significant complications like adrenal insufficiency and pigmentation.

Findings:

  • Adrenalectomy for fertility in CAH demonstrated positive outcomes.
  • Symptomatic management via adrenalectomy led to complications, including adrenal insufficiency and hyperpigmentation.
  • Mean follow-up was 4.2 patient years, highlighting the need for cautious application of this procedure.

Implications:

  • Bilateral adrenalectomy could be a viable option for specific CAH patients desiring fertility.
  • The risks associated with adrenalectomy for symptom control in CAH warrant careful consideration and further investigation.
  • More extensive research is necessary before widespread adoption of adrenalectomy for CAH management.
Abstract

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...